Cao Jianbo, Pickup Stephen, Rosen Mark, Zhou Rong
Department of Radiology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Current address: Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Mol Imaging Biol. 2023 Aug;25(4):638-647. doi: 10.1007/s11307-023-01824-7. Epub 2023 May 11.
We demonstrated earlier in mouse models of pancreatic ductal adenocarcinoma (PDA) that K derived from dynamic contrast-enhanced (DCE) MRI detected microvascular effect induced by PEGPH20, a hyaluronidase which removes stromal hyaluronan, leading to reduced interstitial fluid pressure in the tumor (Clinical Cancer Res (2019) 25: 2314-2322). How the choice of pharmacokinetic (PK) model and arterial input function (AIF) may impact DCE-derived markers for detecting such an effect is not known.
Retrospective analyses of the DCE-MRI of the orthotopic PDA model are performed to examine the impact of individual versus group AIF combined with Tofts model (TM), extended-Tofts model (ETM), or shutter-speed model (SSM) on the ability to detect the microvascular changes induced by PEGPH20 treatment.
Individual AIF exhibit a marked difference in peak gadolinium concentration. However, across all three PK models, k values show a significant correlation between individual versus group-AIF (p < 0.01). Regardless individual or group AIF, when k is obtained from fitting the DCE-MRI data using the SSM, k shows a significant increase after PEGPH20 treatment (p < 0.05 compared to the baseline); %change of k from baseline to post-treatment is also significantly different between PEGPH20 versus vehicle group (p < 0.05). In comparison, when k is derived from the TM, only the use of individual AIF leads to a significant increase of k after PEGPH20 treatment, whereas the %change of k is not different between PEGPH20 versus vehicle group. Group AIF but not individual AIF allows detection of a significant increase of V (derived from the ETM) in PEGPH20 versus vehicle group (p < 0.05). Increase of V is consistent with a large increase of mean capillary lumen area estimated from immunostaining.
Our results suggest that k derived from SSM and V from ETM, both using group AIF, are optimal for the detection of microvascular changes induced by stroma-directed drug PEGPH20. These analyses provide insights in the choice of PK model and AIF for optimal DCE protocol design in mouse pancreatic cancer models.
我们先前在胰腺导管腺癌(PDA)小鼠模型中证明,动态对比增强(DCE)MRI得出的K值可检测到PEGPH20(一种可去除基质透明质酸的透明质酸酶)诱导的微血管效应,从而降低肿瘤间质液压力(《临床癌症研究》(2019年)25:2314 - 2322)。尚不清楚药代动力学(PK)模型和动脉输入函数(AIF)的选择如何影响用于检测这种效应的DCE衍生标志物。
对原位PDA模型的DCE - MRI进行回顾性分析,以研究个体AIF与群体AIF结合Tofts模型(TM)、扩展Tofts模型(ETM)或快门速度模型(SSM)对检测PEGPH20治疗诱导的微血管变化能力的影响。
个体AIF在钆浓度峰值上表现出显著差异。然而,在所有三种PK模型中,k值在个体AIF与群体AIF之间显示出显著相关性(p < 0.01)。无论使用个体AIF还是群体AIF,当使用SSM拟合DCE - MRI数据获得k值时,PEGPH20治疗后k值显著增加(与基线相比,p < 0.05);PEGPH20组与载体组之间k值从基线到治疗后的变化百分比也有显著差异(p < 0.05)。相比之下,当k值由TM得出时,仅使用个体AIF会导致PEGPH20治疗后k值显著增加,而PEGPH20组与载体组之间k值的变化百分比无差异。群体AIF而非个体AIF能够检测到PEGPH20组与载体组相比V值(由ETM得出)显著增加(p < 0.05)。V值的增加与免疫染色估计的平均毛细血管腔面积大幅增加一致。
我们的结果表明,使用群体AIF时,由SSM得出的k值和由ETM得出的V值最适合检测基质导向药物PEGPH20诱导的微血管变化。这些分析为小鼠胰腺癌模型中最佳DCE方案设计的PK模型和AIF选择提供了见解。